Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like HAS-BLED Score for Major Bleeding Risk frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the HAS-BLED Score for Major Bleeding Risk?
The HAS-BLED Score for Major Bleeding Risk is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. The HAS-BLED score is used to assess the 1-year risk of major bleeding in patients with atrial fibrillation. It helps clinicians identify modifiable bleeding risk factors before and during anticoagulation therapy, rather than serving as a strict contraindication to anticoagulation. Clinical scoring tools like HAS-BLED Score for Major Bleeding Risk are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Empowers clinicians to focus on modifiable bleeding risk factors rather than inappropriately denying anticoagulation to patients at high risk of stroke.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate HAS-BLED Score for Major Bleeding Risk:
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 2 | Low / Moderate Risk | green |
| ≥ 3 | High Risk | red |
When to Exercise Caution
May be less accurate for patients on newer Direct Oral Anticoagulants (DOACs), as the score was derived from cohorts largely taking Vitamin K Antagonists (Warfarin).
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.
Related Cardiology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Cardiology:
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
HEART Score for Major Cardiac Events
Predicts 6-week risk of major adverse cardiac events (MACE).
Wells' Criteria for Pulmonary Embolism
Calculates the pre-test probability of Pulmonary Embolism (PE).
TIMI Risk Score for UA/NSTEMI
Estimates 14-day mortality, new MI, or urgent revascularization risk in UA/NSTEMI.